PRAISE: PRedictive Accuracy of Initial Stone Burden Evaluation.
Study Details
Study Description
Brief Summary
This study is intended to be a prospective registry of patients undergoing any kind of stone treatment that have a pre-operative CT available. This imaging will be used to measure the stone burden in three different ways: in a single dimension (cumulative stone diameter), in two dimensions (surface area) and in three dimensions (volume).The primary purpose is to identify what way of measuring stone burden is most predictive of outcomes after stone treatment such as stone free status, operative time and complications.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The current EAU and AUA guidelines still base the recommendations for stone treatment on cumulative stone diameter, a linear measurement of the stone burden. Multiple nomograms rather use the stone burden's surface area to predict post-operative outcomes. More recently, volume has been prposed as the most accurate measure of stone burden and the variable to be reported in stone treatment literature. Although inuitively a three dimensional evaluation is most likely the most accurate representation of the stone burden to be treated.
Several reports however have compared different ways of measuring stone burden and could not confidently identify volume as the most accurate predictor of surgical outcomes.
With this study, we aim to prospectively collect data on a large group of patients that have a pre-operative CT scan available. This imaging will be used to assess the stone burden in different ways, linear, two dimensional and three dimensional. Both procedural and post-operative data will be collected to identify which of the measurements is most accurate in predicting outcomes such as stone free status, operative time and complications such as bleeding. Patients can be included regardless of the procedure that is proposed to treat the stone. After inclusion and after having undergone the procedure, at least one post-operative assessment is necessary to be able to evaluate the pre-operative variables against post-operative outcomes.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
extracorporeal shockwave lithotripsy Patients that are included in the study and undergo a shockwave lithotripsy. The pre- and postoperative assessment remains the same across groups |
Diagnostic Test: Computed Tomography, CSD
Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
Diagnostic Test: Computed Tomography, SA
Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
Diagnostic Test: Computed Tomography, 3D
Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
Other Names:
|
uretero(reno)scopy Patients that are included in the study and undergo a semirigid or flexible uretero(reno)scopy. The pre- and postoperative assessment remains the same across groups |
Diagnostic Test: Computed Tomography, CSD
Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
Diagnostic Test: Computed Tomography, SA
Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
Diagnostic Test: Computed Tomography, 3D
Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
Other Names:
|
percutaneous nephrolithotomy Patients that are included in the study and undergo a percutaneous nephrolithotomy. The pre- and postoperative assessment remains the same across groups |
Diagnostic Test: Computed Tomography, CSD
Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
Diagnostic Test: Computed Tomography, SA
Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
Diagnostic Test: Computed Tomography, 3D
Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Stone Free Status [1 day to 3 months]
Any residual stone fragments after the initial treatment
Secondary Outcome Measures
- Operative Time [intra-operative]
Time needed to treat the stone burden as measured during one treatment session
- Complication [30 days]
Any complication thet can be attributed to the procedure that was performed
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Availability of computed tomography imaging
-
Undergoing any of the previously described procedures: extracorporeal shockwave lithotripsy, uretero(reno)scopy or percutaneous nephrolithotomy
-
Able to read and understand the information regarding the study and able to provide informed consent
Exclusion Criteria:
-
Under the stated age limit
-
No pre-operative computed tomography imaging available
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Ghent | Gent | Eastern-Flanders | Belgium | 9000 |
Sponsors and Collaborators
- University Hospital, Ghent
- EAU Young Academic Urologists Urolithiasis and Endourology Working Group
- European Association of Urology Section of Uro-Technology
- Endourological Society TOWER Research Team
Investigators
- Principal Investigator: Thomas Tailly, MD, University Hospital, Ghent
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- B6702020000464